VERVE THERAPEUTICS INC's ticker is and the CUSIP is 92539P901. A total of 4 filers reported holding VERVE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,586 | -92.3% | 1,100 | -89.1% | 0.00% | -100.0% |
| Q2 2023 | $189,375 | -47.5% | 10,100 | -59.6% | 0.00% | 0.0% |
| Q1 2023 | $360,500 | +51.5% | 25,000 | +103.3% | 0.00% | 0.0% |
| Q4 2022 | $238,005 | -42.2% | 12,300 | +2.5% | 0.00% | 0.0% |
| Q3 2022 | $412,000 | +2646.7% | 12,000 | +1100.0% | 0.00% | – |
| Q2 2022 | $15,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 25,000 | $360,500 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| SIMPLEX TRADING, LLC | 700 | $10 | 0.00% |
| JANE STREET GROUP, LLC | 35,200 | $507,584 | 0.00% |